Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
Guttman-Yassky E, Bahadori L, Brooks L, Clark KL, Grindebacke H, Ho CN, Katial R, Pham TH, Walton C, Datto CJ; HILLIER study group†. Guttman-Yassky E, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1211-e1214. doi: 10.1111/jdv.19195. Epub 2023 Jun 12. J Eur Acad Dermatol Venereol. 2023. PMID: 37178404 Clinical Trial. No abstract available.
Proteomic alterations in patients with atopic dermatitis.
Obi A, Rothenberg-Lausell C, Levit S, Del Duca E, Guttman-Yassky E. Obi A, et al. Among authors: guttman yassky e. Expert Rev Proteomics. 2024 May 22:1-11. doi: 10.1080/14789450.2024.2350938. Online ahead of print. Expert Rev Proteomics. 2024. PMID: 38753434 Review.
Pemphigoid and atopy: A case-control study in the All of Us database.
Powers CM, Piontkowski AJ, Block BR, Orloff J, Guttman-Yassky E, Gulati N. Powers CM, et al. Among authors: guttman yassky e. J Allergy Clin Immunol Pract. 2024 Apr 6:S2213-2198(24)00348-9. doi: 10.1016/j.jaip.2024.04.005. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 38588912 No abstract available.
386 results